Title |
NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders
|
---|---|
Published in |
Neurochemical Research, July 2018
|
DOI | 10.1007/s11064-018-2594-8 |
Pubmed ID | |
Authors |
Chengyan Chu, Yue Gao, Xiaoyan Lan, Aline Thomas, Shen Li |
Abstract |
The neural cell adhesion molecule (NCAM) plays a pivotal role in the development and maintenance of the nervous system via homophilic (NCAM-NCAM) and heterophilic (NCAM-other molecules) interactions. Many synthetic peptides have been engineered to mimic these interactions and induce NCAM-downstream signaling pathways. Such NCAM mimetics have displayed neuritogenic and neuroprotective properties, as well as synaptic modulation in vitro and in vivo. Furthermore, they have been used successfully in preclinical studies to treat neurological disorders including stroke, traumatic brain injury and Alzheimer's disease. This review focuses on recent progress in the development of NCAM mimetic peptides, in particular, on establishing C3, plannexin, and FGL as therapeutic candidates for neurological disorders. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 32 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 5 | 16% |
Student > Master | 4 | 13% |
Student > Ph. D. Student | 4 | 13% |
Researcher | 4 | 13% |
Student > Doctoral Student | 2 | 6% |
Other | 2 | 6% |
Unknown | 11 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 19% |
Neuroscience | 4 | 13% |
Agricultural and Biological Sciences | 2 | 6% |
Medicine and Dentistry | 2 | 6% |
Immunology and Microbiology | 1 | 3% |
Other | 3 | 9% |
Unknown | 14 | 44% |